Skip to content

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

JSPR Jasper Therapeutics, Inc. Common Stock
$0.51 -0.98% 0.00
Notify me if price changes either direction
Interactive Brokers Logotype

Buy JSPR stocks now with Interactive Brokers – the most advanced investment platform

Contents
  • Performance
  • Key stats
  • Financials
  • US politician trades

Jasper Therapeutics, Inc. Common Stock (JSPR)

Loading

Key Stats

Market cap. 16.8M
Enterprise value -10653347
Trailing PE -0.12822784954989
Forward PE -0.7168794
PEG Ratio 0.001360466208639
Enterprise to EBITDA 0.11661482130152
Price to book MRQ 10.108

Financials

Fiscal Year Ends 2025-12-31
Most Recent Quarter (MRQ) 2026-06-30
Diluted EPS TTM -1.04
Current ratio (MRQ) 1.4749521988528
Operating Cash Flow (TTM) -77161000

JSPR trades by the US politicians

Percentage
0% 0 sells
100% 0 buys
Amount
$0 0 sells
$0 0 buys
In the last 0 months

Recent JSPR News

Home

IMPORTANT NOTICE

Finbold is a news and information website. This Site may contain sponsored content, advertisements, and third-party materials, for which Finbold expressly disclaims any liability.

RISK WARNING: Cryptocurrencies are high-risk investments and you should not expect to be protected if something goes wrong. Don’t invest unless you’re prepared to lose all the money you invest. (Click here to learn more about cryptocurrency risks.)

By accessing this Site, you acknowledge that you understand these risks and that Finbold bears no responsibility for any losses, damages, or consequences resulting from your use of the Site or reliance on its content. Click here to learn more.